Cel
Biomarkers are considered as tools to enhance cardiovascular risk estimation. However, the value of biomarkers on risk estimation beyond European risk scores, their comparative impact among different European regions and their role in the drive towards personalised medicine remains uncertain.
Based on harmonised and standardised European population cohorts we have built significant research collaboration, expertise and infrastructure in the EU. We will apply highly innovative SME-driven technologies and perform large-scale biomarker determination to assess the predictive value of existing and emerging biomarkers.
Selection of emerging biomarkers will be based on integrated cutting-edge quantitative proteomic, transcriptomic, metabolomic, and miRNomic datasets established by private and public consortium members that will be disclosed to this consortium. Existing biomarkers will be selected based on non-redundancy and their association with cardiovascular risk and phenotypes. After SME-guided development of innovative assay systems biomarkers will be tested and validated in a stepwise fashion among European populations in primary and secondary prevention. In addition to their impact on risk prediction, their association with lifestyle determinants and cardiovascular phenotypes assessed by ultrasound and MRI technique will be evaluated.
We will establish a BiomarCaRE panel which leads to improved disease prediction among different European populations. International collaborations with world-class clinical trial investigators will add data on the interaction of the BiomarCaRE panel with risk-lowering medication and lifestyle changes. The outcome of SME-driven technology development and clinical validation will undergo a medical technology assessment. The determination of cost-effectiveness will guide further clinical evaluation. These studies will reveal new methods of improved cardiovascular risk estimation and will open the path towards personalised medicine.
Dziedzina nauki
Zaproszenie do składania wniosków
FP7-HEALTH-2011-two-stage
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-FP - Small or medium-scale focused research projectKoordynator
20251 Hamburg
Niemcy
Zobacz na mapie
Uczestnicy (29)
00271 Helsinki
Zobacz na mapie
3511 GC UTRECHT
Zobacz na mapie
3584 CX Utrecht
Zobacz na mapie
85764 Neuherberg
Zobacz na mapie
6020 Innsbruck
Zobacz na mapie
23562 Lubeck
Zobacz na mapie
6060 HALL IN TYROL
Zobacz na mapie
30625 Hannover
Zobacz na mapie
RG27 8DH HARTLEY WINTNEY HANTS
Zobacz na mapie
Zakończenie uczestnictwa
1015 Lausanne
Zobacz na mapie
EC1V 4PY LONDON
Zobacz na mapie
55131 Mainz
Zobacz na mapie
9019 Tromso
Zobacz na mapie
20123 Milano
Zobacz na mapie
17489 Greifswald
Zobacz na mapie
WC1E 6BT London
Zobacz na mapie
BT7 1NN Belfast
Zobacz na mapie
59019 Lille
Zobacz na mapie
08025 Barcelona
Zobacz na mapie
901 87 Umea
Zobacz na mapie
51005 Tartu
Zobacz na mapie
3400 Hillerod
Zobacz na mapie
21100 Varese
Zobacz na mapie
DD1 4HN Dundee
Zobacz na mapie
4031 Basel
Zobacz na mapie
89081 Ulm
Zobacz na mapie
Zakończenie uczestnictwa
L8S 4L8 HAMILTON
Zobacz na mapie
2006 Sydney
Zobacz na mapie
86077 Pozzilli Is
Zobacz na mapie